These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1174 related items for PubMed ID: 28068222

  • 1. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.
    Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, Redpath P, Migaud ME, Apte RS, Uchida K, Yoshino J, Imai SI.
    Cell Metab; 2016 Dec 13; 24(6):795-806. PubMed ID: 28068222
    [Abstract] [Full Text] [Related]

  • 2. Exercise-induced benefits on glucose handling in a model of diet-induced obesity are reduced by concurrent nicotinamide mononucleotide.
    Yu J, Laybutt DR, Kim LJ, Quek LE, Wu LE, Morris MJ, Youngson NA.
    Am J Physiol Endocrinol Metab; 2021 Jul 01; 321(1):E176-E189. PubMed ID: 34121447
    [Abstract] [Full Text] [Related]

  • 3. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X, Hu X, Yang Y, Takata T, Sakurai T.
    Brain Res; 2016 Jul 15; 1643():1-9. PubMed ID: 27130898
    [Abstract] [Full Text] [Related]

  • 4. Administration of Nicotinamide Mononucleotide (NMN) Reduces Metabolic Impairment in Male Mouse Offspring from Obese Mothers.
    Uddin GM, Youngson NA, Chowdhury SS, Hagan C, Sinclair DA, Morris MJ.
    Cells; 2020 Mar 25; 9(4):. PubMed ID: 32218167
    [Abstract] [Full Text] [Related]

  • 5. Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise.
    Uddin GM, Youngson NA, Doyle BM, Sinclair DA, Morris MJ.
    Sci Rep; 2017 Nov 08; 7(1):15063. PubMed ID: 29118320
    [Abstract] [Full Text] [Related]

  • 6. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain.
    Ramanathan C, Lackie T, Williams DH, Simone PS, Zhang Y, Bloomer RJ.
    Nutrients; 2022 Jan 12; 14(2):. PubMed ID: 35057482
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock.
    Sims CA, Guan Y, Mukherjee S, Singh K, Botolin P, Davila A, Baur JA.
    JCI Insight; 2018 Sep 06; 3(17):. PubMed ID: 30185676
    [Abstract] [Full Text] [Related]

  • 9. Nicotinamide mononucleotide ameliorates the depression-like behaviors and is associated with attenuating the disruption of mitochondrial bioenergetics in depressed mice.
    Xie X, Yu C, Zhou J, Xiao Q, Shen Q, Xiong Z, Li Z, Fu Z.
    J Affect Disord; 2020 Feb 15; 263():166-174. PubMed ID: 31818774
    [Abstract] [Full Text] [Related]

  • 10. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
    Nadeeshani H, Li J, Ying T, Zhang B, Lu J.
    J Adv Res; 2022 Mar 15; 37():267-278. PubMed ID: 35499054
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
    Yamaguchi S, Irie J, Mitsuishi M, Uchino Y, Nakaya H, Takemura R, Inagaki E, Kosugi S, Okano H, Yasui M, Tsubota K, Hayashi K, Yoshino J, Itoh H.
    Endocr J; 2024 Feb 28; 71(2):153-169. PubMed ID: 38191197
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nicotinamide Mononucleotide (NMN) Ameliorates Free Fatty Acid-Induced Pancreatic β-Cell Dysfunction via the NAD+/AMPK/SIRT1/HIF-1α Pathway.
    Wang Y, Liu S, Ying L, Zhang K, Li H, Liang N, Xiao L, Luo G.
    Int J Mol Sci; 2024 Sep 30; 25(19):. PubMed ID: 39408861
    [Abstract] [Full Text] [Related]

  • 14. Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells.
    Ru M, Wang W, Zhai Z, Wang R, Li Y, Liang J, Kothari D, Niu K, Wu X.
    Food Funct; 2022 Jul 18; 13(14):7507-7519. PubMed ID: 35678708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects.
    Kiss T, Giles CB, Tarantini S, Yabluchanskiy A, Balasubramanian P, Gautam T, Csipo T, Nyúl-Tóth Á, Lipecz A, Szabo C, Farkas E, Wren JD, Csiszar A, Ungvari Z.
    Geroscience; 2019 Aug 18; 41(4):419-439. PubMed ID: 31463647
    [Abstract] [Full Text] [Related]

  • 17. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
    Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J.
    Adv Nutr; 2023 Nov 18; 14(6):1416-1435. PubMed ID: 37619764
    [Abstract] [Full Text] [Related]

  • 18. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
    Park JH, Long A, Owens K, Kristian T.
    Neurobiol Dis; 2016 Nov 18; 95():102-10. PubMed ID: 27425894
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Administration of Nicotinamide Mononucleotide Mitigates High-fat-diet-induced Physiological Decline in aging mice.
    Zhou AJ, Xiong ZE, Wang L, Chen XX, Wang ZP, Zhang YD, Chen WW, Cai XL, Xu YL, Rong S, Wang T.
    J Nutr; 2024 Oct 16. PubMed ID: 39424071
    [Abstract] [Full Text] [Related]

  • 20. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
    Fletcher RS, Ratajczak J, Doig CL, Oakey LA, Callingham R, Da Silva Xavier G, Garten A, Elhassan YS, Redpath P, Migaud ME, Philp A, Brenner C, Canto C, Lavery GG.
    Mol Metab; 2017 Aug 16; 6(8):819-832. PubMed ID: 28752046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.